Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07531693
Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer
Sponsor: Institut fuer Frauengesundheit
View on ClinicalTrials.gov
Summary
The goal of this observational study is to evaluate how persistently patients with high-risk early breast cancer take abemaciclib 6 months after therapy start. To this end, researchers will perform a retrospective analysis of therapy data.
Official title: Patient Relevant Outcomes Improvement Program in High Risk HR-positive Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2026-02-19
Completion Date
2027-03
Last Updated
2026-04-15
Healthy Volunteers
No
Conditions
Locations (1)
Department of Obstetrics and Gynaecology, Uniklinikum Erlangen
Erlangen, Bavaria, Germany